Kazuichi Okazaki1, Suresh T Chari2, Luca Frulloni3, Markus M Lerch4, Terumi Kamisawa5, Shigeyuki Kawa6, Myung-Hwan Kim7, Philippe Lévy8, Atsushi Masamune9, George Webster10, Tooru Shimosegawa9. 1. Department of Gastroenterology and Hepatology, Kansai Medical University, Hirakata, Japan. Electronic address: okazaki@hirakata.kmu.ac.jp. 2. Mayo Clinic College of Medicine, Rochester, MN 55905, USA. Electronic address: chari.suresh@mayo.edu. 3. Department of Medicine, Pancreas Institute, University of Verona, Verona, Italy. 4. Department of Medicine A, University Medicine Greifswald, Germany. 5. Department of Internal Medicine, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan. 6. Center for Health, Safety, and Environmental Management, Shinshu University, Matsumoto, Japan. 7. Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea. 8. Service de Pancréatologie-Gastroentérologie, Pôle des Maladies de l'Appareil Digestif, Université Denis Diderot-Paris VII Hôpital Beaujon, APHP, Clichy, France. 9. Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan. 10. Pancreaticobiliary Medicine Unit, University College London Hospitals, London, UK.
Abstract
BACKGROUND AND AIMS: The International Consensus Diagnostic Criteria (ICDC) for AIP has proposed two distinctive type of AIP, type 1 and type 2, and enabled us first to differentiate two types of AIP each other. By initial steroid treatment for induction of remission, remission can be successfully induced in almost all subjects with type 1 and type 2 AIP. As relapse rate in type 1 AIP is significantly higher than in type 2 AIP, there has been ongoing debate on how to treat effectively relapse of type 1 AIP. METHODS: By a modified Delphi approach, a panel of international experts has proposed an international consensus on the treatment of AIP after intense discussion and deliberation during an international consensus symposium of the International Association of Pancreatology (IAP) 2016. RESULTS: Individual statements for nine clinical questions with recommendation levels and the therapeutic strategy have been proposed. CONCLUSION: The recommendations are based on the available evidence, and eastern and western experts' opinions to find standard treatment of AIP worldwide. These recommendations can be tailored according to the local expertise and context in the management of individual patients.
BACKGROUND AND AIMS: The International Consensus Diagnostic Criteria (ICDC) for AIP has proposed two distinctive type of AIP, type 1 and type 2, and enabled us first to differentiate two types of AIP each other. By initial steroid treatment for induction of remission, remission can be successfully induced in almost all subjects with type 1 and type 2 AIP. As relapse rate in type 1 AIP is significantly higher than in type 2 AIP, there has been ongoing debate on how to treat effectively relapse of type 1 AIP. METHODS: By a modified Delphi approach, a panel of international experts has proposed an international consensus on the treatment of AIP after intense discussion and deliberation during an international consensus symposium of the International Association of Pancreatology (IAP) 2016. RESULTS: Individual statements for nine clinical questions with recommendation levels and the therapeutic strategy have been proposed. CONCLUSION: The recommendations are based on the available evidence, and eastern and western experts' opinions to find standard treatment of AIP worldwide. These recommendations can be tailored according to the local expertise and context in the management of individual patients.
Authors: J-Matthias Löhr; Ulrich Beuers; Miroslav Vujasinovic; Domenico Alvaro; Jens Brøndum Frøkjær; Frank Buttgereit; Gabriele Capurso; Emma L Culver; Enrique de-Madaria; Emanuel Della-Torre; Sönke Detlefsen; Enrique Dominguez-Muñoz; Piotr Czubkowski; Nils Ewald; Luca Frulloni; Natalya Gubergrits; Deniz Guney Duman; Thilo Hackert; Julio Iglesias-Garcia; Nikolaos Kartalis; Andrea Laghi; Frank Lammert; Fredrik Lindgren; Alexey Okhlobystin; Grzegorz Oracz; Andrea Parniczky; Raffaella Maria Pozzi Mucelli; Vinciane Rebours; Jonas Rosendahl; Nicolas Schleinitz; Alexander Schneider; Eric Fh van Bommel; Caroline Sophie Verbeke; Marie Pierre Vullierme; Heiko Witt Journal: United European Gastroenterol J Date: 2020-06-18 Impact factor: 4.623
Authors: L D Dickerson; A Farooq; F Bano; J Kleeff; R Baron; M Raraty; P Ghaneh; R Sutton; P Whelan; F Campbell; P Healey; J P Neoptolemos; V S Yip Journal: World J Surg Date: 2019-06 Impact factor: 3.352